Back to Search Start Over

Variance of the SGK1 Gene Is Associated with Insulin Secretion in Different European Populations: Results from the TUEF, EUGENE2, and METSIM Studies.

Authors :
Friedrich, Björn
Weyrich, Peter
Alena Stančáková
Jianjung Wang
Kuusisto, Johanna
Laakso, Markku
Sesti, Giorgio
Succurro, Elena
Smith, Ulf
Hansen, Torben
Pedersen, Oluf
Machicao, Fausto
Schäfer, Silke
Lang, Florian
Risler, Teut
Ullrich, Susanne
Stefan, Norbert
Fritsche, Andreas
Häring, Hans-Ulrich
Source :
PLoS ONE; 2008, Vol. 3 Issue 11, p1-6, 6p, 2 Diagrams, 2 Charts, 1 Graph
Publication Year :
2008

Abstract

Hypothesis: Serum- and Glucocorticoid-inducible Kinase 1 (SGK1) is involved in the regulation of insulin secretion and may represent a candidate gene for the development of type 2 diabetes mellitus in humans. Methods: Three independent European populations were analyzed for the association of SGK1 gene (SGK) variations and insulin secretion traits. The German TUEF project provided the screening population (N = 725), and four tagging SNPs (rs1763527, rs1743966, rs1057293, rs9402571) were investigated. EUGENE2 (N = 827) served as a replication cohort for the detected associations. Finally, the detected associations were validated in the METSIM study, providing 3798 non-diabetic and 659 diabetic (type 2) individuals. Results: Carriers of the minor G allele in rs9402571 had significantly higher C-peptide levels in the 2 h OGTT (+10.8%, p = 0.04; dominant model) and higher AUC<subscript>C-Peptide</subscript>/AUCGlc ratios (+7.5%, p = 0.04) compared to homozygous wild type TT carriers in the screening population. As interaction analysis for BMI6rs9402571 was significant (p = 0.04) for the endpoint insulin secretion, we stratified the TUEF cohort for BMI, using a cut off point of BMI = 25. The effect on insulin secretion only remained significant in lean TUEF participants (BMI#25). This finding was replicated in lean EUGENE2 rs9402571 minor allele carriers, who had a significantly higher AUC<subscript>Ins</subscript>/AUC<subscript>Glc</subscript> (TT: 226±7, XG: 246±9; p = 0.019). Accordingly, the METSIM trial revealed a lower prevalence of type 2 diabetes (OR: 0.85; 95%CI: 0.71-1.01; p = 0.065, dominant model) in rs9402571 minor allele carriers. Conclusions: The rs9402571 SGK genotype associates with increased insulin secretion in lean non-diabetic TUEF/EUGENE2 participants and with lower diabetes prevalence in METSIM. Our study in three independent European populations supports the conclusion that SGK variability affects diabetes risk. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
19326203
Volume :
3
Issue :
11
Database :
Complementary Index
Journal :
PLoS ONE
Publication Type :
Academic Journal
Accession number :
55666716
Full Text :
https://doi.org/10.1371/journal.pone.0003506